Cargando…
Current view on novel vaccine technologies to combat human infectious diseases
ABSTRACT: Inactivated and live attenuated vaccines have improved human life and significantly reduced morbidity and mortality of several human infectious diseases. However, these vaccines have faults, such as reactivity or suboptimal efficacy and expensive and time-consuming development and producti...
Autores principales: | Matić, Zrinka, Šantak, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661323/ https://www.ncbi.nlm.nih.gov/pubmed/34889981 http://dx.doi.org/10.1007/s00253-021-11713-0 |
Ejemplares similares
-
The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses—Not Just Another Brick in the Viral Nucleocapsid
por: Šantak, Maja, et al.
Publicado: (2022) -
Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
por: Dhama, Kuldeep, et al.
Publicado: (2020) -
Photoinactivation of mycobacteria to combat infection diseases: current state and perspectives
por: Shleeva, Margarita, et al.
Publicado: (2021) -
Novel targets and strategies to combat borreliosis
por: Strnad, Martin, et al.
Publicado: (2020) -
Solutions against emerging infectious and noninfectious human diseases through the application of baculovirus technologies
por: Targovnik, Alexandra Marisa, et al.
Publicado: (2021)